Sanofi's vaccine production facility to strengthen Singapore's future pandemic readiness
FRENCH healthcare company Sanofi broke ground for a vaccine production facility in Singapore on Wednesday (Apr 20), which is expected to create up to 200 local jobs, while providing greater and flexible vaccine production capacity.
The modular nature of this "evolutive vaccine facility" (EVF) makes it possible to produce 3 to 4 different vaccines simultaneously, in contrast to typical vaccine manufacturing facilities that can only produce 1 type of vaccine at a time.
This will enable more flexible manufacturing of multiple vaccines and biological platforms, including mRNA, enzymes and monoclonal antibodies, the company said in its press statement.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
China’s Xi lands in Serbia after talking Ukraine, trade in France
Stormy Daniels details alleged sex with Trump at hush money trial
Indian vote body tells X to remove Modi party video targeting Muslims, opposition
Inflation-hit Argentina has a new top banknote, worth just US$10
Trade between Singapore and Asean was at S$295.6 billion in 2023
One out of every 24 New York City residents is a millionaire